Metraipolis › archive › dc_5510328be2a6

Orelabrutinib plus reduced-dose whole brain radiotherapy in elderly primary central nervous system lymphoma: a case report — Europe PMC PMID:41256329

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41256329
DOI
10.3389/fonc.2025.1693481
License (as archived)
solo-consultazione
Archived
2026-11-08T19:58:48.463Z
SHA-256 of the archived text
b09550ca01928f10542a3dc2f1be6963ef91ef9bd996fcd681af514a0cb64693
Stable URL of this page
https://metraipolis.com/documento/dc_5510328be2a6

How to cite

Orelabrutinib plus reduced-dose whole brain radiotherapy in elderly primary central nervous system lymphoma: a case report — Europe PMC PMID:41256329 — Europe PMC (en), https://europepmc.org/article/MED/41256329 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5510328be2a6 (Metraipolis archive dc_5510328be2a6, sha256 b09550ca01928f10542a3dc2f1be6963ef91ef9bd996fcd681af514a0cb64693)
BibTeX
@misc{dc5510328be2a6,
  title = {Orelabrutinib plus reduced-dose whole brain radiotherapy in elderly primary central nervous system lymphoma: a case report — Europe PMC PMID:41256329},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41256329},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5510328be2a6; sha256 b09550ca01928f10542a3dc2f1be6963ef91ef9bd996fcd681af514a0cb64693},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41256329. Agents can read the archived copy with the MCP tool read_document.